Monashee Investment Management LLC Bluebird Bio, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.32 - $4.83 $660,000 - $2.42 Million	500,000 New	500,000 $690,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $4.48 Million - $5.69 Million	-130,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$27.12 - $45.97 $3.53 Million - $5.98 Million	130,000 New	130,000 $7.94 Million
Q1 2018 May 10, 2018	SELL	$105.8 - $150.94 $3.97 Million - $5.66 Million	-37,500 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $3.05 Million - $4.9 Million	37,500	37,500 $6.68 Million

128

62.8M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $598M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.